LEADER 01157nam--2200385---450- 001 990003017300203316 005 20090113134753.0 010 $a978-88-8350-112-8 035 $a000301730 035 $aUSA01000301730 035 $a(ALEPH)000301730USA01 035 $a000301730 100 $a20071120d2007----km-y0itay50------ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $a<> qualità delle valutazioni$euna metodologia per riconoscere e misurare l'errore$fLuigi Guatri 210 $aMilano$cEGEA/Università Bocconi$dcopyr. 2007 215 $a328 p.$d23 cm 225 2 $aBiblioteca del valore 410 0$12001$aBiblioteca del valore 454 1$12001 461 1$1001-------$12001 606 0 $aQualità$xAziende 676 $a658.562 700 1$aGUATRI,$bLuigi$027932 801 0$aIT$bsalbc$gISBD 912 $a990003017300203316 951 $a658.562 GUA 1 (IRA 6 1076)$b15983 EC.$cIRA 6$d00063485 959 $aBK 969 $aECO 979 $aFIORELLA$b90$c20071120$lUSA01$h1033 979 $aRSIAV2$b90$c20090113$lUSA01$h1347 996 $aQualità delle valutazioni$91024985 997 $aUNISA LEADER 01977oam 2200457Ia 450 001 9910698954603321 005 20090820090806.0 035 $a(CKB)5470000002398329 035 $a(OCoLC)421097512 035 $a(EXLCZ)995470000002398329 100 $a20090702d2008 ua 0 101 0 $aeng 135 $auran||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aGuidance for industry$b[electronic resource] $epostmarketing adverse event reporting for medical products and dietary supplements during an influenza pandemic 210 1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Office of Counterterrorism and Emerging Threats :$cCenter for Drug Evaluation and Research :$cCenter for Biologics Evaluation and Research :$cCenter for Devices and Radiological Health :$cCenter for Food Safety and Applied Nutrition,$d[2008] 215 $a1 online resource (12 pages) 300 $a"Draft guidance". 300 $a"Procedural". 300 $a"December 2008". 517 $aGuidance for industry 606 $aDrugs$xSide effects$xReporting$xGovernment policy$zUnited States 606 $aDietary supplements$xGovernment policy$zUnited States 606 $aInfluenza 615 0$aDrugs$xSide effects$xReporting$xGovernment policy 615 0$aDietary supplements$xGovernment policy 615 0$aInfluenza. 712 02$aUnited States.$bFood and Drug Administration.$bOffice of Counterterrorism and Emerging Threats. 712 02$aCenter for Drug Evaluation and Research (U.S.) 712 02$aCenter for Biologics Evaluation and Research (U.S.) 712 02$aCenter for Devices and Radiological Health (U.S.) 712 02$aCenter for Food Safety and Applied Nutrition (U.S.) 801 0$bGPO 801 1$bGPO 801 2$bGPO 906 $aBOOK 912 $a9910698954603321 996 $aGuidance for industry$93434577 997 $aUNINA